← Open Payments lookup

NPI 1871379321: Open Payments

NPI 1871379321. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$322 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $322

Food & beverage: $322
CompanyPaymentsAmount
Novo Nordisk Inc3$73
SHIELD THERAPEUTICS INC3$56
Exact Sciences Corporation2$41
Lilly USA, LLC2$41
AstraZeneca Pharmaceuticals LP1$24
SCPHARMACEUTICALS INC.1$19
Amgen Inc.1$19
ABBVIE INC.1$18
Phadia US Inc.1$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: Ozempic, ACCRUFER, WAINUA, ZEPBOUND, The Cologuard Plus Collection Kit, Cologuard Collection Kit, FUROSCIX, REPATHA.